[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"cochlear-implant\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:cochlear-implant":24},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,9,0,[8,42,77,105,135,155,181,203,223],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":27,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100053617","retrospectively-investigating-longitudinal-outcomes-in-med-el-sonata-2-cochlear-implant-recipients-100053617",false,"NCT07697911","Retrospectively Investigating Longitudinal Outcomes in MED-EL SONATA 2 Cochlear Implant Recipients.","Longitudinal Outcomes of SONATA 2 Cochlear Implant Recipients: a Retrospective Study","LORIS","Inclusion Criteria:\n\n* At least one MED-EL SONATA 2 cochlear implant with a compatible MED-EL audio processor\n\nExclusion Criteria:\n\n* Lack of compliance with any inclusion criteria","ALL",{"count":19,"type":20},200,"ESTIMATED","OBSERVATIONAL","MED-EL Cochlear Implants (CI) provide auditory sensations via electrical stimulation of the auditory pathways for severely to profoundly hearing-impaired individuals who obtain little or no benefit from acoustic amplification in the best aided condition.\n\nHowever, there is only few evidence from large long-term observational studies available to gain knowledge on clinical effectiveness of cochlear implants. With continued pressure on healthcare system budgets, there is an increasing demand for evidence-based research that demonstrates an intervention is effective in the real-world environment across large and diverse populations. Currently, there is a paucity of data concerning the long-term outcomes of subjects implanted with a SONATA 2 cochlear implant from representative samples of the population. This retrospective study aims at analyzing SONATA 2 cochlear implant data from clinical routine.",[24,25,26],"Cochlear Implant","SONATA 2","Cochlear Implantation",[28],"retrospective data collection","NOT_YET_RECRUITING","2026-07-06",{"date":32,"type":33},"2026-07-13","ACTUAL",{"date":35,"type":20},"2026-09",{"date":37,"type":20},"2027-05",{"name":39,"class":40},"MED-EL Elektromedizinische Geräte GesmbH","INDUSTRY",2,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":46,"acronym":4,"eligibilityCriteria":47,"healthyVolunteers":11,"sex":17,"minAge":48,"maxAge":49,"enrollmentInfo":50,"targetDuration":4,"studyType":52,"phases":53,"briefSummary":55,"conditions":56,"keywords":60,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":76},"100645169","patient-oriented-research-to-optimize-cochlear-implant-outcomes-100645169","NCT07678879","Patient-Oriented Research to Optimize Cochlear Implant Outcomes","Inclusion Criteria:\n\n1. Adults between ages of 18 years and 95 years\n2. Native language is American English\n3. Have one or two CIs from any of the three FDA-approved CI manufacturers (Cochlear Americas, Advanced Bionics, MED-EL).\n4. Experience of \\>6 of CI use.\n\nExclusion Criteria:\n\n1. Score 24 or below on a visual Mini-Mental State Exam (MMSE; Folstein et al., 1975) to rule out dementia\n2. Known diagnosis of dementia\n3. Under the age of 18 years\n4. Unable to read and write in English (WRAT score \\\u003C70)\n5. Poorer than 20\u002F40 near vision on near-vision screening.","18 Years","95 Years",{"count":51,"type":20},100,"INTERVENTIONAL",[54],"NA","The rationale is that only through understanding how individual Cochlear Implant (CI) patients respond to interventions investigators further develop precision-medicine approaches to optimize outcomes. In the proposed research study to investigate the hypotheses, investigators will address two Specific Aims:\n\nSpecific Aim #1: Define the auditory (bottom-up), cognitive-linguistic (top-down), and functional neuroimaging profiles of adult CI users. Investigators will enroll experienced CI users (\\> 6 months of CI use).\n\nSpecific Aim #2: Determine the feasibility of \"auditory\" (bottom-up) and \"cognitive\" (top-down) interventions to improve speech processing in adult CI users.\n\nThe main hypothesis is that the two interventions are feasible. Investigators also hypothesize that our study protocol will detect the variance in auditory processing profiles and that investigators will show promise in improving both speech processing (using speech recognition and Functional Near-Infrared Spectroscopy (fNIRS) responses)) and real-world functioning (using patient-reported measures), compared with no intervention.\n\nAdditional hypotheses to be explored are that baseline profile (as defined in Aim #1) will impact the magnitude of participants' responses to the interventions, as will order of interventions (Auditory-Cognitive vs. Cognitive-Auditory, AC vs CA).",[24,57,58,59],"Cochlear Implant Users","Cochlear Implant Recipients","Cochlear Implant Listeners",[61,62,63,64,65],"CI users","CI","cochlear implant","cochlear implant user","cochlear","2026-06-24",{"date":68,"type":33},"2026-07-01",{"date":70,"type":20},"2026-07",{"date":72,"type":20},"2032-06",{"name":74,"class":75},"Vanderbilt University Medical Center","OTHER",1,{"id":78,"slug":79,"hasResults":11,"nctId":80,"briefTitle":81,"officialTitle":81,"acronym":4,"eligibilityCriteria":82,"healthyVolunteers":83,"sex":17,"minAge":84,"maxAge":4,"enrollmentInfo":85,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":86,"conditions":87,"keywords":91,"overallStatus":95,"whyStopped":4,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":99,"completionDateStruct":101,"leadSponsor":103,"locationsCount":76},"100620323","binaural-cue-sensitivity-in-children-and-adults-with-combined-electric-and-acoustic-stimulation-100620323","NCT07356128","Binaural Cue Sensitivity in Children and Adults With Combined Electric and Acoustic Stimulation","Inclusion Criteria:\n\n* Pediatric EAS: aged 5-17; Adult EAS: aged 18+ years\n* At least one CI and bilateral mild to profound sensorineural hearing loss with unaided audiometric thresholds ≤ 80 dB HL at 125 and 250 Hz, in both ears.\n\n  * Willingness to use EAS technology in the implanted ear(s) to be verified via data logging\n  * Nonverbal cognitive abilities within the typical range\n  * No co-morbid diagnoses such as autism, auditory neuropathy, neurological disorder, or general cognitive impairment\n  * Use of spoken English as main mode of communication\n* For children and adults with normal hearing, they will demonstrate audiometric thresholds 20 dB HL or better from 250-8000 Hz\n\nExclusion Criteria:\n\n* single-sided deafness (SSD)",true,"5 Years",{"count":19,"type":20},"There is a rapidly growing population of adult and pediatric cochlear implant (CI) recipients with acoustic hearing preservation in the implanted ear(s) allowing for combined Electric and binaural Acoustic Stimulation (EAS). Despite the rapid technological and surgical advancements that have led to this increased prevalence, there is limited research on EAS outcomes-particularly for pediatric EAS listeners-including the expected trajectory of benefit following EAS fitting and underlying mechanisms driving benefit in EAS users of all ages. Thus, the purpose of this project is to provide a comprehensive description of behavioral and electrophysiologic measures of binaural hearing in adults and children both with normal hearing and EAS users.",[88,24,89,90],"Bilateral Sensorineural Hearing Loss","Hearing Preservation","Electric and Acoustic Simulation",[92,63,93,94],"sensorineural hearing loss","electric and acoustic stimulation (EAS)","hearing preservation","RECRUITING","2026-01-20",{"date":98,"type":33},"2026-01-21",{"date":100,"type":33},"2025-07-01",{"date":102,"type":20},"2028-11-30",{"name":104,"class":75},"Hearts for Hearing",{"id":106,"slug":107,"hasResults":11,"nctId":108,"briefTitle":109,"officialTitle":110,"acronym":4,"eligibilityCriteria":111,"healthyVolunteers":11,"sex":17,"minAge":112,"maxAge":113,"enrollmentInfo":114,"targetDuration":4,"studyType":52,"phases":116,"briefSummary":117,"conditions":118,"keywords":120,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":127,"lastUpdatePostDateStruct":128,"startDateStruct":130,"completionDateStruct":131,"leadSponsor":133,"locationsCount":76},"100615816","crescendo-childrens-music-enhancement-in-cochlear-implant-users-100615816","NCT07297524","CRESCENDO: ChildREn's muSiC ENhancement in Cochlear Implant Users","A Single-Center, Single-Arm Exploratory Study to Evaluate the Impact of Multimodal Acoustic Therapy (MAT) on Objective and Subjective Auditory Perception During a 12-Week Intervention and a 12-Week Follow-Up in Pediatric and Adolescent Cochlear Implant Users","Inclusion Criteria:\n\n* Individuals with cochlear implants\n* Korean patients aged 10 to 19 years\n* Capable of using a smartphone\n* Scored ≤80% on MCI pre-assessment\n* Voluntarily agreed to participate in this study\n\nExclusion Criteria:\n\n* Has systemic medical conditions (e.g., cancer, stroke) that limit daily functioning\n* Has intellectual disability, congenital malformation, or other neurological disorders affecting language or cognitive abilities\n* Has diagnosed emotional disorders such as depression or anxiety\n* Primarily uses sign language for daily communication\n* Has undergone cochlear implant revision surgery\n* Has prior experience with the investigational auditory rehabilitation application used in this study","10 Years","19 Years",{"count":115,"type":20},25,[54],"This exploratory, single-center, single-arm study investigates the impact of a 12-week Multimodal Acoustic Therapy (MAT) intervention followed by a 12-week follow-up period on both objective and subjective auditory perception in pediatric cochlear implant users.",[24,119],"Hearing Loss",[121,24,122,123,124,125,126],"Multimodal Acoustic Therapy","Pediatric Cochlear Implant Users","Adolescent Cochlear Implant Users","Auditory Rehabilitation","Mobile Application","Digital Health Intervention","2025-12-09",{"date":129,"type":33},"2025-12-22",{"date":129,"type":20},{"date":132,"type":20},"2026-08-31",{"name":134,"class":75},"Seoul National University Hospital",{"id":136,"slug":137,"hasResults":11,"nctId":138,"briefTitle":139,"officialTitle":81,"acronym":4,"eligibilityCriteria":140,"healthyVolunteers":83,"sex":17,"minAge":84,"maxAge":4,"enrollmentInfo":141,"targetDuration":4,"studyType":52,"phases":143,"briefSummary":144,"conditions":145,"keywords":4,"overallStatus":95,"whyStopped":4,"lastUpdateSubmitDate":146,"lastUpdatePostDateStruct":147,"startDateStruct":149,"completionDateStruct":151,"leadSponsor":153,"locationsCount":154},"100510189","combined-electric-and-acoustic-hearing-eas-in-children-and-adults-100510189","NCT05923203","Combined Electric and Acoustic Hearing (EAS) in Children and Adults","Inclusion Criteria:\n\n1. Children aged 5 to 17 years of age with either normal hearing (n=40) or at least 1 cochlear implant (CI) and binaural low-frequency acoustic hearing (n=40); adults aged 18+ years with either normal hearing (n=40) or at least 1 CI and binaural low-frequency acoustic hearing (n=40).\n2. Experimental participants must have at least one CI and bilateral mild to severe sensorineural hearing loss For CI participants, audiometric thresholds in the non-CI ear must be consistent with at least a mild sensorineural hearing loss; that is, the investigators will not be enrolling participants with single-sided deafness (SSD) For CI participants, unaided audiometric thresholds must be less than or equal to 80 dB HL for 125 and 250 Hz, in both ears.\n3. Nonverbal cognitive abilities within the typical range for all participants; adult participants must also pass cognitive screening via Montreal Cognitive Assessment (MoCA or HI-MoCA).\n4. No confounding diagnosis such as autism, auditory neuropathy, neurological disorder, or general cognitive impairment.\n5. Willingness to use EAS technology in the implanted ear(s) to be verified via data logging from cochlear implant and hearing aid software.\n\nExclusion Criteria:\n\n1. Nonverbal intelligence standard score \\\u003C 85 (for any participant).\n2. MoCA or HI-MoCA score \\\u003C 26 for adult participants.",{"count":142,"type":20},160,[54],"Cochlear implants are surgically implanted devices which restore the ability to hear to the hearing impaired. Improvements in surgery and electrodes have results in an increased number of adults and children who have residual hearing and can benefit from electric and acoustic hearing in the same ear. This is called Electric Acoustic Stimulation (EAS). Many studies have shown that adult EAS users show significant benefits for speech understanding in noise and spatial hearing tasks as compared to a CI paired only with a contralateral HA. Even though this type of hearing is becoming more common, there is limited research on how it can be beneficial to children with CIs. The benefits of this study are a greater understanding of the participant's speech understanding, binaural processing, and spatial hearing. The results will help audiologists and researcher better understand how cochlear implants work, specifically when using electric and acoustic hearing in the same ear.",[24,119],"2025-10-15",{"date":148,"type":33},"2025-10-20",{"date":150,"type":33},"2022-12-05",{"date":152,"type":20},"2028-08-31",{"name":104,"class":75},4,{"id":156,"slug":157,"hasResults":11,"nctId":158,"briefTitle":159,"officialTitle":160,"acronym":161,"eligibilityCriteria":162,"healthyVolunteers":11,"sex":17,"minAge":48,"maxAge":163,"enrollmentInfo":164,"targetDuration":4,"studyType":52,"phases":166,"briefSummary":167,"conditions":168,"keywords":169,"overallStatus":95,"whyStopped":4,"lastUpdateSubmitDate":172,"lastUpdatePostDateStruct":173,"startDateStruct":175,"completionDateStruct":177,"leadSponsor":179,"locationsCount":180},"100527047","dexamethasone-eluting-cochlear-implant-a-pivotal-study-100527047","NCT06142682","Dexamethasone Eluting Cochlear Implant: a Pivotal Study","Dexamethasone-Eluting Cochlear Implant Electrode (CIDEXEL): Pivotal Study","CDEX2","Inclusion Criteria:\n\nMinimum age of eighteen (18) years at time of enrolment.\n\n* Hearing loss on the ipsilateral ear (see Figure 8 for the specific audiological criteria).\n* A functional auditory nerve in the ear to be implanted.\n* Subjects reporting to having used an optimally fit hearing aids for a minimum of three months before the decision that a cochlear implant is the preferential option.\n* Cochlea anatomy compatible with the insertion of a FLEX28 electrode array.\n* Compatibility with a soft surgery approach as per clinical practice at the site.\n* Post-lingual hearing impairment.\n* Subject fulfilling indication criteria for a CI according to the local professional standards, as reported by the implanting surgeon.\n* General health condition, psychological and emotional condition deemed compatible with the treatment and tests performed in this study and realistic expectations, as deemed appropriate by the implanting surgeon.\n* Signed and dated informed consent before the start of any study-specific procedure.\n\nExclusion Criteria:\n\n* Lack of compliance with any inclusion criterion.\n* Previously having received a cochlear implant on the ear chosen for placing the IMD.\n* Evidence of ossification or any other cochlear anomaly that might prevent complete insertion of the electrode array or might cause increased risk of infection (e.g. dysplastic cochlea), as confirmed by medical examination and\u002For as per CT\u002FMRT.\n* Evidence of anatomic abnormalities that would prevent appropriate placement of the stimulator housing in the bone of the skull.\n* Known allergic reaction or intolerance to the materials used in the implant (including medical grade silicone, platinum, iridium, parylene c, DEX).\n* Known absence of cochlear development or if the cause of deafness is non-functionality of the auditory nerve and\u002For the upper auditory pathway.\n* Evidence of active external or middle ear infection or history of recurrent middle ear infection in the ear to be implanted.\n* Evidence of perforated tympanic membrane in the ear to be implanted.\n* Patient reporting immunosuppressive therapy or corticosteroids therapy in the 4 weeks before enrolment.\n* Evidence of concomitant use of medicinal substances that, in the opinion of the investigator, could alter the therapeutic efficacy of dexamethasone.\n* Unwillingness or inability of the candidate to comply with all investigational requirements.\n* Evidence of medical contraindications to surgery of the middle and inner ear and anaesthesia.\n* Additional disabilities that would prevent or restrict participation in the audiological and medical evaluations required of the clinical investigation.\n* Subject not capable of giving consent.\n* Individual subjected to court-ordered or government-authorized deprivation of liberty as defined by § 27 MPDG.\n* Evidence of Pregnancy.","85 Years",{"count":165,"type":20},60,[54],"The newly developed MED-EL Cochlear Implant Mi1250 +FLEX28 DEX (CIDEXEL) incorporates the anti-inflammatory agent dexamethasone (DEX) into the electrode array. The passive elution of DEX during the post-implantation period has the purpose of counteracting the increase of the post-operative impedance induced by the insertion trauma.\n\nThe aim of this clinical investigation is to obtain confirmatory data concerning safety and performances of the investigational device in the clinical population.",[24],[170,62,171],"cochlear implantation","Dexamethasone","2025-08-11",{"date":174,"type":33},"2025-08-12",{"date":176,"type":33},"2024-09-02",{"date":178,"type":20},"2026-05-30",{"name":39,"class":40},7,{"id":182,"slug":183,"hasResults":11,"nctId":184,"briefTitle":185,"officialTitle":186,"acronym":4,"eligibilityCriteria":187,"healthyVolunteers":83,"sex":17,"minAge":48,"maxAge":4,"enrollmentInfo":188,"targetDuration":4,"studyType":52,"phases":190,"briefSummary":191,"conditions":192,"keywords":4,"overallStatus":95,"whyStopped":4,"lastUpdateSubmitDate":195,"lastUpdatePostDateStruct":196,"startDateStruct":197,"completionDateStruct":199,"leadSponsor":201,"locationsCount":76},"100466935","anatomy-based-fitting-in-cochear-implant-users-100466935","NCT05360212","Anatomy-based Fitting in Cochear Implant Users","Anatomy-based Fitting in Unexperienced Cochlear Implant Users. Programación Basada en la anatomía en Usuarios Nuevos de Implante Coclear.","Inclusion Criteria:\n\n* Age ≥ 18 years\n* Post-lingual onset of severe to profound sensory-neural hearing loss in the implanted ear(s)\n* Post-OP CT scan of the CI electrode available\n* Subject implanted with MED-EL cochlear implant(s)\n* Subjects received a Flex28 or FlexSoft electrode\n* Subject planned to receive a SONNET 2 \u002FRONDO3 audio processor on the newly implanted side\n* Audio processor not yet activated on the newly implanted side\n* The most apical active electrode contact has to be inserted at least 450°\n* Minimum of 10 active channels can be activated\n* Fluent in Spanish\n* Signed and dated ICF before the start of any study-specific procedure\n\nSpecific inclusion criteria for the possible study groups • Bilateral CI users: Bilateral CI implantation SONNET 2\u002FRONDO3 audio processor on the first ear implanted\n\n* 40% speech recognition a monosyllabic word Test in quiet at 65 dB SPL (last time tested) on the already implanted side\n* 40% speech recognition in a sentence test in noise (10 dB SNR) on the already implanted side First activation of the already implanted side between 3 and 12 months prior to study inclusion\n\n  • Unilateral CI users: Unilateral CI implantation CI user with contralateral hearing ≥ 60 dB (PTA measured at 500, 1000, 2000, and 4000 Hz)\n\n  • SSD CI users: Unilateral CI implantation CI user with contralateral hearing ≤30 dB (PTA measured at 500, 1000, 2000, and 4000 Hz) Interaural threshold gap ≥40 dB\n\n  • Bimodal CI users: Unilateral CI implantation Contralateral ear adequately fitted with a hearing aid CI user with contralateral hearing ≥30 dB (PTA measured at 500, 1000, 2000, and 4000 Hz) CI user with contralateral hearing ≤55 dB (PTA measured at 500, 1000, 2000, and 4000 Hz) Interaural threshold gap ≥15 dB\n\nExclusion Criteria:\n\n* Lack of compliance with any inclusion criteria\n* EAS user (user of an EAS audio processor)\n* Implanted with C40+, C40X and C40C\n* Implanted with an ABI or Split electrode array\n* Known allergic reactions to components of the investigational medical device\n* Anything that, in the opinion of the Investigator, would place the subject at increased risk or preclude the subject's full compliance with or completion of the study",{"count":189,"type":20},30,[54],"In this study, the performance with the CI is investigated over time in three groups of freshly implanted CI users. Both the standard frequency-band distribution and anatomy-based fitting will be used to compare outcomes.",[24,193,194],"Outcomes","Quality of Life","2025-08-06",{"date":174,"type":33},{"date":198,"type":33},"2022-03-11",{"date":200,"type":20},"2026-12-31",{"name":202,"class":75},"Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz",{"id":204,"slug":205,"hasResults":11,"nctId":206,"briefTitle":207,"officialTitle":207,"acronym":4,"eligibilityCriteria":208,"healthyVolunteers":83,"sex":17,"minAge":209,"maxAge":4,"enrollmentInfo":210,"targetDuration":212,"studyType":21,"phases":4,"briefSummary":213,"conditions":214,"keywords":4,"overallStatus":95,"whyStopped":4,"lastUpdateSubmitDate":195,"lastUpdatePostDateStruct":217,"startDateStruct":218,"completionDateStruct":220,"leadSponsor":222,"locationsCount":76},"100463821","analysis-of-musical-and-voice-skills-in-children-and-adult-cochlear-implant-users-100463821","NCT05319678","Analysis of Musical and Voice Skills in Children and Adult Cochlear Implant Users","Inclusion Criteria:\n\n* Minimum age of 6 years.\n* Patients aged 6-17 years must have been implanted before the age of 3 years (to ensure adequate CI performance).\n* Minimum 12 months experience with the device\n* Indications: unilateral (one CI), bilateral (two CIs), bimodal (one CI in one ear and a hearing aid in the other)\n* At least 80% of electrodes active at the time of assessment.\n* Fluency in Spanish\n* Signed and dated informed consent prior to starting any study procedure.\n\nExclusion Criteria:\n\n* Not meet inclusion criteria.\n* Prelingual or perilingual adults.\n* Disability in addition to hearing impairment (e.g., mental disability).","6 Years",{"count":211,"type":20},80,"12 Months","Aims: To evaluate the perception and enjoyment of music in cochlear implant (CI) users using specific questionnaires, and comparing their results with a control group of subjects with normal hearing (NH). To analyze the musical abilities of implantees using the musical tool Meludia, and compare the results with the control group. To perfom a voice analysis in implanted patients, compare it with their NH peers, and check if an association with musical perception is observed.\n\nDesign: Cross-sectional study, both the CI recipients and NH control subjects were assessed once.\n\nSetting and subjects: Pre-or perilingual patients aged 6 to 17 years old, and postlingual adults who underwent cochlear implantation from 2000 to January 2023 at La Paz University Hospital. Control group is set up with their NH peers.\n\nStudy Variables: Socio-demographic and clinical (current age, age at implantation, sex, educational level) variables will be collected, as well as hearing loss (aetiology, duration of deafness), and surgical (type of implant, complete or partial insertion of the electrodes, date of surgery) data. Data from CI fitting (number of active electrodes, type of audio processor) and hearing outcomes with the CI will also be reviewed.\n\nOutcome variables: Specific musical skills questionnaires for adults: Munich Music Questionnaire (MuMu) and Music Related Quality of Life Questionnaire (MuRQoL), which will be validated. Musical questionnaire developed specifically for subjects between 6-17 years old. Musical tool (Meludia) to assess musical perception. Praat software for voice analysis. Analysis of the impact of the different audiological, sociodemographic and clinical variables on hearing outcomes, and on musical perception after cochlear implantation, and comparison with the NH control group.",[24,215,216],"Music","Voice",{"date":174,"type":33},{"date":219,"type":33},"2022-02-10",{"date":221,"type":20},"2025-12-31",{"name":202,"class":75},{"id":224,"slug":225,"hasResults":11,"nctId":226,"briefTitle":227,"officialTitle":227,"acronym":228,"eligibilityCriteria":229,"healthyVolunteers":11,"sex":17,"minAge":230,"maxAge":209,"enrollmentInfo":231,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":233,"conditions":234,"keywords":236,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":242,"lastUpdatePostDateStruct":243,"startDateStruct":245,"completionDateStruct":246,"leadSponsor":248,"locationsCount":76},"100586373","assessment-of-the-development-of-social-cognition-in-a-deaf-child-with-a-cochlear-implant--a-study-using-a-standardized-questionnaire-100586373","NCT06914531","Assessment of the Development of Social Cognition in a Deaf Child With a Cochlear Implant : A Study Using a Standardized Questionnaire","1OL1","Inclusion Criteria:\n\n* Children aged 3 to 6 years old, who received a cochlear implant before the age of 15 months, who use their implant(s) and have a supportive family environment,\n* Children with at least one cochlear implant undergoing speech therapy and are being monitored by the Pediatric Cochlear Implant Unit at Toulouse University Hospital,\n* Children who are able to communicate: through speech, gestures, or French Sign Language,\n* Children and their family whose mother tongue is French, - Social security coverage.\n\nExclusion Criteria:\n\n* Cognitive or psychological impairment preventing the child from communicating,\n* Other sensory or motor deficits that may interfere with pointing,\n* Unstable psychiatric illness,\n* Child whose parents both benefit from a legal protection measure.","3 Years",{"count":232,"type":20},6,"This study investigates the adaptability of a questionnaire assessing social cognition in children with cochlear implants aged 3 to 6 years, implanted before the age of 15 months. The primary objective is to evaluate the comprehensibility and relevance of the questionnaire in this population, considering their specific communication modes and cognitive profiles. By analysing response variability, communication abilities, and social interaction patterns, the study aims to refine the tool for accurate assessment. The findings will contribute to improving evaluation methods for social cognition in young deaf children.",[235,24],"Deaf Children",[237,238,239,240,241],"children","Cochlear Implants","Deafness","Social cognitive skills","Emotions skills","2025-03-31",{"date":244,"type":33},"2025-04-06",{"date":242,"type":20},{"date":247,"type":20},"2026-03-03",{"name":249,"class":75},"University Hospital, Toulouse"]